학술논문

A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy
Document Type
Journal
Source
NEUROBIOLOGY OF DISEASE; NOV 2021, 159 p105507 12p.
Subject
Language
English
ISSN
1095953X